How have ELAB shares performed in 2023?

Elevai Labs' stock was trading at $3.40 at the beginning of 2023. Since then, ELAB shares have decreased by 46.2% and is now trading at $1.8282. View the best growth stocks for 2023 here .

When is Elevai Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 11th 2024. View our ELAB earnings forecast .

How were Elevai Labs' earnings last quarter?

Elevai Labs, Inc. (NASDAQ:ELAB) posted its quarterly earnings data on Monday, December, 11th. The company reported ($0.08) EPS for the quarter. The company earned $0.56 million during the quarter.

When did Elevai Labs IPO?

(ELAB) raised $6 million in an initial public offering (IPO) on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities acted as the underwriter for the IPO.

When does the company's quiet period expire?

Elevai Labs' quiet period expires on Monday, January 1st. Elevai Labs had issued 1,500,000 shares in its public offering on November 21st. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Elevai Labs?

Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ELAB

Elevai Labs (ELAB) Stock Price, News & Analysis

$1.83

+0.03 (+1.67%)

(As of 12/29/2023 ET)

Compare

Today's Range: $1.78
▼
$1.85
50-Day Range: N/A
52-Week Range: $1.54
▼
$4.24

Volume: 9,818 shs
Average Volume: 114,658 shs
Market Capitalization: $31.68 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Headlines SEC Filings Social Media

About Elevai Labs Stock (NASDAQ:ELAB)

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

ELAB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ELAB Stock News Headlines

December 25, 2023 | americanbankingnews.com

Elevai Labs, Inc.'s (NASDAQ:ELAB) Quiet Period Will End on January 1st

December 12, 2023 | investorplace.com

ELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024

December 31, 2023 | Behind the Markets (Ad)

New Year's Sale: Get 12 Months of Stock Picks for $9.00

Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this.

December 11, 2023 | finance.yahoo.com

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023

December 8, 2023 | morningstar.com

Elevai Labs Inc ELAB

December 7, 2023 | finance.yahoo.com

ELEVAI Labs, Inc. Expands International Distribution into Europe

November 29, 2023 | finance.yahoo.com

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products

November 27, 2023 | investing.com

Elevai Labs Inc (ELAB)

December 31, 2023 | Behind the Markets (Ad)

New Year's Sale: Get 12 Months of Stock Picks for $9.00

November 24, 2023 | finance.yahoo.com

ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering

November 22, 2023 | marketwatch.com

Elevai Labs Prices 1.5 Million-Share IPO at $4 a Share

November 22, 2023 | finance.yahoo.com

Elevai Labs, Inc. Common Stock (ELAB)

November 22, 2023 | msn.com

Skincare company Elevai Labs sees stock dip 5% following $6M IPO

See More Headlines

Receive ELAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevai Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/11/2023
Today: 12/31/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/11/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ELAB
Previous Symbol: NASDAQ:ELAB
CUSIP: N/A
CIK: 1840563
Web: elevaiskincare.com
Phone: 866-794-4940
Fax: N/A
Employees: 16
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 17,330,000
Free Float: N/A
Market Cap: $31.68 million
Optionable: N/A
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Jordan R. Plews Ph.D. (Age 40)
Co-Founder, President, CEO & Director
Comp: $210k
Ms. Brenda Buechler (Age 53)
Chief Marketing Officer
Comp: $195k
Mr. Christoph Kraneiss (Age 52)
Chief Commercial Officer
Comp: $188.55k
Dr. Hatem Abou-Sayed F.A.C.S. (Age 52)
FACS, M.B.A., M.D., MBA, Co-Founder, Chief Medical Officer & Director
Mr. Graydon Bensler C.F.A. (Age 32)
CFO, Secretary & Director

Key Competitors

View All Competitors

ELAB Stock Analysis - Frequently Asked Questions

How have ELAB shares performed in 2023?: Elevai Labs' stock was trading at $3.40 at the beginning of 2023. Since then, ELAB shares have decreased by 46.2% and is now trading at $1.8282.
View the best growth stocks for 2023 here.
When is Elevai Labs' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 11th 2024.
View our ELAB earnings forecast.
How were Elevai Labs' earnings last quarter?: Elevai Labs, Inc. (NASDAQ:ELAB) posted its quarterly earnings data on Monday, December, 11th. The company reported ($0.08) EPS for the quarter. The company earned $0.56 million during the quarter.
When did Elevai Labs IPO?: (ELAB) raised $6 million in an initial public offering (IPO) on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities acted as the underwriter for the IPO.

When does the company's quiet period expire?: Elevai Labs' quiet period expires on Monday, January 1st. Elevai Labs had issued 1,500,000 shares in its public offering on November 21st. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
How do I buy shares of Elevai Labs?: Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ELAB) was last updated on 12/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial